Which statement about screening in neurofibromatosis type 2 is true?

Prepare for the NBME Form 9 Test with our engaging quiz. Utilize multiple choice questions and explanations. Excel in your exam with thorough study tools and resources!

Multiple Choice

Which statement about screening in neurofibromatosis type 2 is true?

Explanation:
In neurofibromatosis type 2, the biggest risk is development of intracranial tumors, especially bilateral vestibular schwannomas, which can progress silently. Because these tumors can grow before symptoms appear, regular brain imaging is essential to catch them early and guide treatment to protect hearing and balance. While eye problems can occur in NF2, annual eye exams do not replace the need for CNS tumor surveillance, and the idea that neither or both modalities are unnecessary doesn’t fit the disease’s risks. Therefore, yearly brain MRI is the best-supported screening approach.

In neurofibromatosis type 2, the biggest risk is development of intracranial tumors, especially bilateral vestibular schwannomas, which can progress silently. Because these tumors can grow before symptoms appear, regular brain imaging is essential to catch them early and guide treatment to protect hearing and balance. While eye problems can occur in NF2, annual eye exams do not replace the need for CNS tumor surveillance, and the idea that neither or both modalities are unnecessary doesn’t fit the disease’s risks. Therefore, yearly brain MRI is the best-supported screening approach.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy